MassMutual Private Wealth & Trust
DXCM icon

MassMutual Private Wealth & Trust’s DexCom DXCM Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$89.1K Sell
1,033
-114
-10% -$9.49K ﹤0.01% 604
2026
Q2 		$77.2K Buy
1,147
+153
+15% +$10.2K ﹤0.01% 646
2026
Q1 		$62.4K Buy
994
+373
+60% +$26K ﹤0.01% 690
2025
Q4 		$41.2K Sell
621
-458
-42% -$29.6K ﹤0.01% 853
2025
Q3 		$72.6K Sell
1,079
-46
-4% -$3.64K ﹤0.01% 684
2025
Q2 		$98.2K Buy
1,125
+217
+24% +$17K ﹤0.01% 596
2025
Q1 		$62K Buy
908
+75
+9% +$6.12K ﹤0.01% 673
2024
Q4 		$64.8K Buy
833
+265
+47% +$19.6K ﹤0.01% 679
2024
Q3 		$38.1K Sell
568
-582
-51% -$47.8K ﹤0.01% 735
2024
Q2 		$130K Buy
1,150
+221
+24% +$27.9K ﹤0.01% 463
2024
Q1 		$129K Buy
929
+64
+7% +$8.04K ﹤0.01% 440
2023
Q4 		$107K Buy
865
+18
+2% +$1.84K ﹤0.01% 453
2023
Q3 		$79K Sell
847
-154
-15% -$17.4K ﹤0.01% 496
2023
Q2 		$129K Buy
1,001
+247
+33% +$29.9K ﹤0.01% 407
2023
Q1 		$87.6K Buy
754
+202
+37% +$22.6K ﹤0.01% 439
2022
Q4 		$63K Buy
552
+57
+12% +$6.26K ﹤0.01% 459
2022
Q3 		$40K Buy
495
+181
+58% +$15.3K ﹤0.01% 488
2022
Q2 		$23K Buy
314
+102
+48% +$9.31K ﹤0.01% 551
2022
Q1 		$27K Buy
212
+52
+33% +$5.69K ﹤0.01% 543
2021
Q4 		$21K Buy
160
+12
+8% +$1.72K ﹤0.01% 595
2021
Q3 		$20K Sell
148
-428
-74% -$54K ﹤0.01% 599
2021
Q2 		$61K Sell
576
-296
-34% -$28.4K ﹤0.01% 451
2021
Q1 		$78K Buy
872
+16
+2% +$1.5K ﹤0.01% 406
2020
Q4 		$79K Buy
856
+56
+7% +$5K ﹤0.01% 409
2020
Q3 		$82K Buy
+800
New +$83.6K ﹤0.01% 384
2017
Q4 		– Sell
-120
Closed -$1.47K – 929
2017
Q3 		$1.47K Hold
120
– – ﹤0.01% 950
2017
Q2 		$2.2K Sell
120
-640
-84% -$11.8K ﹤0.01% 896
2017
Q1 		$16.1K Sell
760
-3,332
-81% -$65K ﹤0.01% 623
2016
Q4 		$61.1K Buy
+4,092
New +$72.5K 0.01% 335

Other funds holding DXCM

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.6B AUM 22.09% 1-Year Est. Return

MassMutual Private Wealth & Trust's DXCM Position: Q3 2026 in Review

MassMutual Private Wealth & Trust reduced its DexCom (DXCM) stake by 9.9% in Q3 2026, selling an estimated $9.49K and leaving 1,033 shares worth $89.1K. The position accounts for ﹤0.01% of the portfolio, ranked #604.

MassMutual Private Wealth & Trust first reported a position in DXCM in Q4 2016 and has held it in 29 quarters since. The position peaked at $130K in Q2 2024. 620 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • MassMutual Private Wealth & Trust held 1,033 shares of DexCom worth $89.1K as of Q3 2026.
  • MassMutual Private Wealth & Trust sold 114 DexCom shares in Q3 2026, an estimated $9.49K.
  • DexCom made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #604 holding.
  • MassMutual Private Wealth & Trust first reported a position in DexCom in Q4 2016 and has held it in 29 quarters since.
  • MassMutual Private Wealth & Trust's DexCom position peaked at $130K in Q2 2024.
  • 620 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.